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Abstract
AIM: To examine the activation of the Nalp3 inflamma-
some and its downstream targets following lipopoly-
saccharide (LPS)-induced stimulation in the liver. 
METHODS: Six-to-eight-week-old C57BL/6 chow fed 
mice were injected intraperitoneally with 0.5 μg/g 
bodyweight LPS and sacrificed 2, 4, 6, 18 or 24 h later. 
LPS-induced liver damage was confirmed by a bio-
chemical assay to detect alanine aminotransferase (ALT) 
levels. To determine if LPS stimulation in the liver led 
to activation of the inflammasome, real-time quantita-
tive polymerase chain reaction was used to evaluate 
the mRNA expression of components of the Nalp3 in-
flammasome. Enzyme-linked immunosorbent assays 
were used to determine the protein expression levels 
of several downstream targets of the Nalp3 inflamma-
some, including caspase-1 and two cytokine targets of 
caspase-1, interleukin (IL)-1β and IL-18.
RESULTS: We found that LPS injection resulted in 
liver damage as indicated by elevated ALT levels. This 
was associated with a significant increase in both 
mRNA and protein levels of the proinflammatory cy-
tokine tumor necrosis factor (TNF)-α in the liver, as 
well as increased levels of TNFs in serum. We showed 
that LPS stimulation led to upregulation of mRNA lev-
els in the liver for all the receptor components of the 
inflammasome, including Nalp3, Nalp1, pannexin-1 
and the adaptor molecule apoptosis-associated speck-
like, caspase recruitment domain-domain containing 
protein. We also found increased levels of mRNA and 
protein for caspase-1, a downstream target of the 
inflammasome. In addition, LPS challenge led to in-
creased levels of both mRNA and protein in the liver 
for two cytokine targets of caspase-1, IL-1β and IL-18. 
Interestingly, substantial baseline expression of pre-IL-
1β and pre-IL-18 was found in the liver. Inflammasome 
and caspase-1 activation was indicated by the signifi-
cant increase in the active forms of IL-1β and IL-18 
after LPS stimulation.
CONCLUSION: Our results show that the Nalp3 inflam-
masome is upregulated and activated in the liver in re-
sponse to LPS stimulation. 
© 2011 Baishideng. All rights reserved.
Key words: Endotoxin; Nod-like receptor; Interleukin-
1β; Interleukin-18; Caspase-1
Peer reviewer: Eddie Wisse, Professor, Cell Biology and His-
tology of the Faculty of Medicine and Pharmacy, Free University 
of Brussels, Laarbeeklaan 103, B 1090 Brussels-Jette, Belgium 
Ganz M, Csak T, Nath B, Szabo G. Lipopolysaccharide induces 
and activates the Nalp3 inflammasome in the liver. World J 
Gastroenterol 2011; 17(43): 4772-4778  Available from: URL: 
http://www.wjgnet.com/1007-9327/full/v17/i43/4772.htm  DOI: 
http://dx.doi.org/10.3748/wjg.v17.i43.4772
INTRODUCTION
The endotoxin lipopolysaccharide (LPS), a component 
of  Gram-negative bacteria, plays an important role in 
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acute liver injury as well as chronic liver diseases includ-
ing fatty liver associated with either alcohol consump-
tion or metabolic syndrome and obesity[1,2]. LPS has also 
been implicated in insulin resistance as well as in steato-
hepatitis in non-alcoholic fatty liver disease[3-5]. Increas-
ing evidence suggests that gut-derived LPS through the 
gut-liver axis affects the extent of  liver damage in many 
different types of  inflammatory liver diseases[6]. LPS is 
a prototypical ligand for the pattern recognition recep-
tor (PRR), Toll-like receptor 4 (TLR4). TLR4 induces 
downstream signaling via the MyD88 adapter molecule 
and induces production of  proinflammatory cytokines 
through activation of  the regulatory factor nuclear factor 
(NF)-κB[6]. In the liver, TLR4 is expressed in both pa-
renchymal and immune cells, thereby providing potential 
for LPS-induced activation[7].
Studies have shown that the Nalp3 inflammasome 
is activated by both pattern associated molecular pat-
terns (PAMPs), including LPS and bacterial RNA, and 
danger-associated molecular patterns (DAMPs)[8,9]. The 
Nalp3 inflammasome is a caspase-1 activating multipro-
tein complex, which has been implicated in numerous 
inflammatory processes and human diseases including 
gout, pseudogout, contact hypersensitivity, and most re-
cently Alzheimer’s disease[10,11]. Furthermore, mutations 
in the Nalp3 gene that lead to gain-of-function muta-
tions, result in several hereditary syndromes including: 
Muckle-Wells syndrome, familial cold autoinflammatory 
syndrome, and chronic infantile neurological cutaneous 
and articular syndrome[12]. 
In response to stimulation by either DAMPs or PAMPs, 
Nalp3 interacts with pro-caspase-1 through the adap-
tor molecule [apoptosis-associated speck-like, caspase 
recruitment domain (CARD)-domain containing protein 
(ASC)] to form the inflammasome, which leads to acti-
vation of  caspase-1. Active caspase-1, previously known 
as interleukin (IL)-1β converting enzyme, a heterodimer 
of  p20 and p10 subunits, is the central effector protein 
of  the inflammasome complex and promotes the cleav-
age of  pro-IL-1β, pro-IL-18 and pro-IL-33 to their 
biologically active, mature forms[13]. In addition, active 
caspase-1 has been shown to cleave other substances, 
such as caspase-7 and sterol regulatory element-binding 
proteins, therefore playing a pivotal role in cell death and 
survival[14]. 
The mRNA levels of  the components the Nalp3 in-
flammasome are expressed in the eye, heart and lung in 
response to LPS stimulation[15]. Although mRNA levels 
of  IL-1β have also been shown to increase in the liver 
in response to LPS stimulation, the role of  the Nalp3 
inflammasome in the liver in response to LPS stimula-
tion has not been determined[16]. In the liver, the Nalp3 
inflammasome is upregulated upon acetaminophen-
induced toxicity[17] and the contribution of  Nalp3 has 
been described in Propionibacterium acnes and LPS-induced 
acute liver injury[18]; however, a role for Nalp3 in other 
liver conditions has not been identified. 
Although the role of  the proinflammatory cytokine, 
tumor necrosis factor (TNF)α, has been extensively 
studied in both alcoholic and non-alcoholic fatty liver 
disease, the role of  IL-1β and the inflammasome has 
yet to be explored. LPS plays an important role in liver 
disease; elevated LPS levels are detected in the portal 
and systemic blood of  patients with alcoholic and non-
alcoholic fatty liver disease[19,20]. Furthermore, there is in-
creased sensitivity to LPS in both alcoholic liver disease 
and fatty liver disease[21]. Here, we examined if  LPS in-
duce the Nalp3 inflammasome in the liver. In this study, 
we showed that LPS stimulation led to induction of  the 
components of  the Nalp3 inflammasome at both the 
mRNA and protein level in the liver and this is associ-
ated with increased IL-1β production.
MATERIALS AND METHODS
Mice 
Six-to-eight-week-old wild-type C57BL/6 chow fed mice 
received intraperitoneal injections of  0.5 μg/g LPS in 
PBS (Sigma, St Louis, MO, United States) (three mice 
per group) for 2, 4, 6, 18 and 24 h. Serum was separated 
from whole blood and stored at -80 ℃. Liver samples 
were snap frozen in liquid nitrogen or stored in RNAl-
ater (Qiagen Sciences, Germantown, MD, United States) 
for RNA extraction. All animals received proper care in 
agreement with animal protocols at the University of  
Massachusetts Medical School Institutional Animal Use 
and Care Committee.
Biochemical alanine aminotransferase assay 
Serum alanine aminotransferase (ALT) was determined 
using a kinetic method (DTEK LLC, Bensalem, PA, 
United States).
RNA analysis 
RNA was purified from livers using the RNeasy kit (Qia-
gen Sciences) and on-column DNA digestion. cDNA 
was transcribed with the Reverse Transcription System 
(Promega, Madison, WI, United States). Real-time quan-
titative polymerase chain reaction (qPCR) was performed 
using iCycler (Bio-Rad Laboratories, Hercules, CA, Unit-
ed States) as described previously[22]. Primer sequences 
are shown in Table 1.
Cytokine enzyme-linked immunosorbent assay 
measurements 
Whole cell lysates were extracted from liver tissue as pre-
viously described[22]. These lysates were assayed for ma-
ture IL-1β (R and D Systems, Minneapolis, MN, United 
States), TNF-α, total IL-18, and total IL-1β (BD Biosci-
ences, United States). Serum was also assayed for mature 
IL-1β (R and D Systems).
Statistical analysis
Statistical significance was determined using Student’s t 
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test (two-tailed distribution). Data are presented as mean 
± SE and were considered significant at P < 0.05. ALT 
statistical significance was determined using the non-
parametric Kruskal-Wallis test followed by the Mann-
Whitney test. 
RESULTS
LPS induces liver injury and inflammatory cytokines 
Gut-derived LPS plays a role in several inflammatory 
liver diseases[6]. To evaluate the effects of  LPS on the 
liver, we injected wild-type mice with LPS for 2, 4, 6, 
18 or 24 h and monitored ALT levels to evaluate liver 
injury. We found increased ALT levels in sera from 
mice injected with LPS at the 4-18-h time points, reach-
ing statistically significant levels at 4 h, indicating LPS-
induced liver damage (Figure 1).  
It has been shown that LPS-induced signaling 
through TLR4 results in production of  proinflammato-
ry cytokines, one of  which, TNF-α, has been linked to 
liver damage[23,24]. We identified significant elevation in 
liver TNF-α mRNA expression at all time points after 
LPS stimulation compared to the unstimulated controls 
(Figure 2A). TNF-α protein levels were undetectable in 
liver tissue from unstimulated controls but were signifi-
cantly increased at all time points after LPS stimulation 
with a maximal increase at 2 h (Figure 2B).
LPS upregulates mRNA expression of Nalp3 
inflammasome components 
For complete function, the inflammasome requires ex-
pression of  its various components including Nalp3, 
ASC (the adapter molecule), and caspase-1[8,10]. We inves-
tigated the mRNA levels of  the different types of  inflam-
masomes, including the Nalp1 and Nlrc4 inflammasomes. 
Our examination revealed a significant increase in liver 
mRNA of  Nalp3 after ≥ 4 h LPS stimulation, with a 
peak at 6 h (Figure 3A). Upregulation of  the inflamma-
some was not limited to Nalp3, and there was a signifi-
cant increase in Nalp1 (sevenfold) and Nlrc4 (3.5-fold) 
mRNA at 24 h compared to the unstimulated controls 
(P < 0.01, P = 0.04, respectively, data not shown). We 
also analyzed the mRNA of  other components of  the 
inflammasome including the pyrin and CARD-domain-
containing adaptor ASC; caspase-1, an inflammatory 
caspase; and pannexin-1, a hemi-channel that is recruited 
upon activation of  the P2X7 receptor and is a necessary 
component for inflammasome activation[25]. The mRNA 
levels of  ASC gradually increased at each time point after 
LPS stimulation (Figure 3B), whereas caspase-1 levels 
peaked at 6 h and pannexin-1 mRNA levels peaked at 6 h 
(Figure 3C and D).
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 Target gene Forward primer (5' → 3') Reverse primer (5' → 3')
  18S GTA ACC CGT TGA ACC CCA TT CCA TCC AAT CGG TAG TAG CG
  TNF-α GAA GTT CCC AAA TGG CCT CC GTG AGG GTC TGG GCC ATA GA
  IL-1β TCT TTG AAG TTG ACG GAC CC TGA GTG ATA CTG CCT GCC TG
  IL-1RA TCA GAT CTG CAC TCA ATG CC CTG GTG TTT GAC CTG GGA GT
  Caspase-1 AGA TGG CAC ATT TCC AGG AC GAT CCT CCA GCA ACT TC
  ASC GA GCT GCT GAC AGT GCA AC GCC ACA GCT CCA GAC TCT TC
  Nalp3 AGC CTT CCA GGA TCC TCT TC CTT GGG CAG TTT CTT TC
  Nlrc4 TGG TGA CAA TAG GGC TCC TC CTG TTC CCT TTG CTC ACC TC
  Nalp1 TGG CAC ATC CTA GGG AAA TC TCC TCA CGT GAC AGC AGA AC
  Pannexin-1 TGT GGC TGC ACA AGT TCT TC ACA GAC TCT GCC CCA CAT TC
Table 1  Real-time polymerase chain reaction primers
TNF: Tumor necrosis factor; IL: Interleukin; ASC: Apoptosis-associated 
speck-like, caspase recruitment domain-domain containing protein.
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Figure 1  Lipopolysaccharide stimulation results in liver damage. C57BL/6 
wild-type chow-fed mice (three per group) were injected intraperitoneally with li-
popolysaccharide (LPS) for 2, 4, 6, 18 or 24 h. Serum was separated from whole 
blood and analyzed for alanine aminotransferase (ALT), which was significantly 
increased after 4 h of LPS stimulation. Mean ± SD are shown. aP < 0.01. 
Control      2         4          6         18        24
                       Hours after LPS
a
a
a
a a
TNF-α mRNA120
100
80
60
40
20
0
m
R
N
A 
fo
ld
 c
ha
ng
e
Control     2          4          6         18        24
                     Hours after LPS
200
150
100
50
0
TNF-α protein
TN
F-
α 
(p
g/
m
L)
a
a
a
a a
A
B
Figure 2  Inflammation in the liver is seen after lipopolysaccharide stimu-
lation. A: Tumor necrosis factor (TNF)-α mRNA in liver tissue was significantly 
increased at all time points after lipopolysaccharide (LPS) stimulation. TNF-α 
mRNA was analyzed by real-time quantitative polymerase chain reaction and 
normalized to 18S. The values are shown as a fold change to the non-stimu-
lated LPS control; B: Similarly, TNF-α protein was significantly elevated in liver 
tissue following LPS stimulation as detected by enzyme-linked immunosorbent 
assay. Protein levels were normalized to total protein concentration in each 
tissue sample. Mean ± SD are shown. n = 3 for each group (except at 4 h LPS 
stimulation, where n = 2 due to an outlier), aP < 0.01.
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Activation of the inflammasome results in increased 
levels of total IL-18, total IL-1β, and mature IL-1β 
LPS stimulation has been shown to increase levels of  
pro-IL-1β transcripts[26]. However, production of  the 
biologically active IL-1β and IL-18 requires the mature 
caspase-1 to cleave the precursor forms into their mature 
forms[27]. First, we evaluated mRNA levels of  IL-1β and 
IL-18 and found that IL-1β mRNA levels were signifi-
cantly increased at all time points post-LPS stimulation 
peaking at 2 h (Figure 4A). Induction of  IL-18 mRNA 
by LPS was modest but reached statistical significance at 
the 6-h time point (Figure 4B). There was also induction 
of  the mRNA for the IL-1 receptor antagonist after LPS 
stimulation in the liver (Figure 4C).
We sought to determine whether the increase in mRNA 
correlated with increased protein production for IL-1β 
and IL-18. We found basal expression of  pro-IL-1β pro-
tein in the livers of  unstimulated control mice and this 
was significantly upregulated at 2 h after LPS stimulation 
(Figure 5A). More importantly, we observed a significant 
increase in mature IL-1β protein in liver tissue at all time 
points post-LPS stimulation compared to the controls, in 
which no mature IL-1β was detected (Figure 5B). Consis-
tent with inflammasome activation, we found increased 
serum IL-1β levels in mice after stimulation with LPS 
for 2 and 6 h (Figure 5C). Investigation of  IL-18, which 
is also cleaved by caspase-1, revealed a significant in-
crease in total IL-18 in the liver at all time points follow-
ing LPS injection (Figure 5D). 
DISCUSSION
Although many molecules and compounds activate the 
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Figure 3  Lipopolysaccharide stimulation increased Nalp3 inflammasome 
mRNA expression in liver tissue. Liver RNA analysis of Nalp3 (A), apoptosis-
associated speck-like, caspase recruitment domain-domain containing protein 
(ASC) (B), caspase-1 (C) and pannexin-1 (D) were analyzed by real-time 
quantitative polymerase chain reaction. The values were normalized to 18S and 
are shown as a fold increase to the non-lipopolysaccharide (LPS) stimulated 
control. Mean ± SD are shown. n = 3 per group, aP < 0.01, bP < 0.03, cP < 0.05.
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Figure 4  Lipopolysaccharide stimulation increased interleukin (IL)-1β and 
IL-18 mRNA, and IL-1RA transcription in the liver. Liver mRNA levels of IL-
1β (A), IL-18 (B) and IL-1RA (C) were analyzed by real-time quantitative poly-
merase chain reaction and normalized to 18S. Mean ± SD are shown. n = 3 per 
group [except at 2 h lipopolysaccharide (LPS) stimulation, where n = 2 due to 
outlier], aP < 0.01, bP < 0.03.
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Nalp3 inflammasome both in vitro and in vivo[8], the role 
of  Nalp3 inflammasome in a healthy liver following LPS 
stimulation has not been determined. Our novel findings 
demonstrate upregulation of  the Nalp3 inflammasome 
in the liver in response to LPS stimulation, both at the 
mRNA and protein levels. We also show for the first 
time that the components of  the inflammasome path-
way, including ASC and caspase-1, are upregulated in the 
liver after LPS challenge and this results in functional 
activation of  the inflammasome and caspase-1, indicated 
by IL-1β and IL-18 secretion. 
LPS is recognized by TLR4, which induces an intra-
cellular signaling cascade leading to activation of  NF-
κB, as well as the production of  pro-IL-1β and pro-
IL-18[28]. Previous studies have suggested that signaling 
through the TLRs alone is insufficient to generate the 
production of  mature IL-1β and IL-18, and that a sec-
ond signal is needed that leads to ionic perturbation[29]. 
These perturbations may include ATP signaling through 
the P2X7 channel, leading to changes in intracellular 
potassium concentrations and membrane perturbations. 
The physiological importance of  ATP in IL-1β secretion 
is unclear and the second signal that leads to cleavage 
of  pro-IL-1β in the liver is still under investigation[30]. In 
vitro studies have shown that a second signal is needed in 
addition to LPS to obtain cleavage of  pro-IL-1β[31]. It is 
possible that a DAMP released by injured cells could act 
as the second signal. In vivo studies, however, have shown 
that LPS alone is sufficient to increase cleavage of  IL-1β 
and IL-18[31]. Our novel data demonstrate that, after in 
vivo LPS challenge, the inflammasome is activated in the 
liver and this results in increased inflammasome function 
and IL-1β secretion. We found that LPS stimulation not 
only increased IL-1β mRNA levels and the expression 
of  pro-IL-1β protein, but it significantly increased the 
levels of  the 18-kDa form of  mature IL-1β in the liver. 
Secretion of  mature IL-1β also resulted in elevated IL-
1β in the serum. Interestingly, we found significant levels 
of  pro-IL-1β protein expressed in the liver without ex-
ogenous stimulation. This suggests that the exogenous 
LPS probably provided the second signal for IL-1β pro-
duction. The mechanisms for the presence of  pro-IL-1β 
protein in the liver remain to be determined, however, 
one possibility is stimulation via PAMPs, such as LPS, 
which are being constantly supplied by the gut through 
the portal vein to the liver[6].
Cleavage of  pro-IL-1β is mediated by activated cas-
pase-1; consistent with this, we found increased levels of  
IL-1β protein in the serum after LPS challenge. The oth-
er target of  the caspase-1 complex and inflammasome 
activation is IL-18. Consistent with LPS-induced inflam-
masome and caspase-1 activation, we found an increase 
in IL-18 mRNA and total IL-18 levels in the liver. Due 
to limitations of  the detection assay, we could not distin-
guish between the mature form of  IL-18 and pro-IL-18, 
but the increase in total IL-18 after LPS stimulation was 
most likely due to an increase in both.
 We found elevated basal levels of  pro-IL-1β in the 
liver, and pro-IL-1β was further increased by LPS with 
the highest levels at 2 h following stimulation. It is likely 
that LPS-induced inflammasome activation can cleave the 
pre-existing pro-IL-1β to the mature form by caspase-1. 
In addition to activation of  the Nalp3 inflammasome, 
our data suggests that other types of  caspase-1-activating 
inflammasomes, Nalp1 and Nlrc4, may also play a role in 
caspase-1 activation and subsequent IL-1β cleavage in the 
liver. Our data showed that both Nalp1 and Nlrc4 mRNA 
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Figure 5  Lipopolysaccharide increased interleukin-1β and interleukin-18 
protein. Protein level was detected in liver tissue by enzyme-linked immuno-
sorbent assay for total-interleukin (IL)-1β (pro-IL-1β and cleaved IL-1β) (A), 
cleaved IL-1β in the liver tissue (B),cleaved IL-1β in the serum (C) and total 
IL-18 (pro-IL-18 and cleaved IL-18) (D) in liver tissue. The values shown are 
the fold change compared to non-Lipopolysaccharide (LPS) stimulated control. 
Protein levels were normalized to total protein concentrations in each tissue 
sample. Mean ± SD are shown. n = 3 per group (except at 2 h LPS stimulation, 
where n = 2 due to an outlier), aP < 0.01.
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levels were upregulated in the liver following LPS stimu-
lation. This suggests that other inflammasome-activating 
signals lead to full activation in the liver.
The contribution of  the Nalp3 inflammasome to 
inflammation in the liver in response to LPS stimulation 
may have implications for several different liver diseases. 
Increased gut-derived LPS has been shown to contribute 
to liver inflammation in alcoholic and non-alcoholic fatty 
liver diseases, as well as other forms of  liver damage 
such as hepatitis C virus infection[32]. In healthy subjects, 
the liver plays a central role in elimination of  gut-derived 
endotoxins and other pathogens to maintain immune 
homeostasis[33]. Thus, it is tempting to speculate that gut-
derived ligands of  TLRs constantly entering the liver 
could contribute to the high basal expression of  pro-
IL-1β found in the liver in our experiments. The high 
basal expression of  pro-IL-1β represents the first step 
of  inflammasome activation, and this appears to provide 
a pre-activated state where even single LPS stimulation 
can result in inflammasome activation, as seen in the 
liver after in vivo LPS challenge in our experiments. The 
specific role of  Nalp3 and the inflammasome remains to 
be evaluated in different types of  liver diseases where in-
flammation is related to LPS and other pathogen-derived 
or endogenous danger signals.
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COMMENTS
Background
The endotoxin lipopolysaccharide (LPS) is a component of Gram-negative 
bacteria, and plays an important role in both acute liver injury as well as 
chronic liver diseases, including fatty liver associated with either alcohol con-
sumption or metabolic syndrome and obesity. Several pathogen-associated 
molecular patterns, including LPS, induce inflammasome activation, an intra-
cellular multiprotein complex leading to release of inflammatory cytokines and 
cell death. 
Research frontiers
Inflammasomes are required for effective clearance of several viral and bacte-
rial pathogens. In addition, inflammasomes have been reported to play a major 
role in several diseases with sterile inflammation such as gout, Alzheimer’s 
disease, atherosclerosis and type 2 diabetes. Here, the authors show the con-
tribution of the Nalp3 inflammasome to LPS-induced inflammation in the liver. 
Innovations and breakthroughs
Recently, the contribution of the Nalp3 inflammasome to Propionibacterium 
acnes plus LPS-induced acute liver injury has been described. Here, authors 
show the increased expression and role of the inflammasome in healthy liver 
following LPS stimulation.
Applications
The contribution of the Nalp3 inflammasome to inflammation in the liver in 
response to LPS stimulation may have implications for several liver diseases, 
including alcoholic and non-alcoholic fatty liver disease, as well as hepatitis C 
virus infection where the role of gut-derived endotoxin has been shown previ-
ously. A better understanding of the pathological mechanism may help future 
attempts to develop effective therapy. 
Terminology
Nalp3, also called cryporin is a nucleotide oligomerization domain-like receptor 
that forms one of the most characterized inflammasome complexes.
Peer review
This is a well done study that examines the role of the inflammasome in the 
liver following LPS exposure. 
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